AI Assistant
Blog
Pricing
Log In
Sign Up
Pretreatment with IFN-α increases resistance to imatinib mesylate in patients with chronic myelocytic leukemia
Details
Cite
Export
Add to List
The content you want is available to Zendy users.
Already have an account? Click
here.
to sign in.
